Study genes to learn how treatment affects children
Part of Cancer clinical trials.
This study looks at genetic (DNA) differences to better understand why treatments work differently for children at St. Jude. It may help doctors choose safer or more effective treatments in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at St. Jude (or be a parent/family member connected to a St. Jude patient)
- You can be a parent or family member, or a non-patient volunteer related to St. Jude care
- You (and the patient, if applicable) must give informed consent before joining
- If a child patient is involved, the child’s assent/parent’s permission must be obtained first
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study collects children’s normal and tumor tissue (or blood-related normal samples) and reads their DNA/RNA to look at genetic information. It may help researchers understand cancer-related changes and improve future testing, even when the goal isn’t to treat you directly.
This study collects and studies tissue or bone marrow samples from certain childhood tumors. The goal is to learn what’s going on inside the cancer (using molecular testing) to better understand the disease and how it may respond to treatment.
This study collects information from children who are currently being treated or followed at St. Jude for childhood cancer. It helps researchers understand care outcomes and improve future planning.
This study interviews parents who lost a child to cancer at St. Jude. It aims to learn from your experience to improve care for other families.
This study looks at the DNA and other biology from skin lesions (like melanoma or unusual pigmented moles) in children and teens. It aims to better understand what these tumors are and how they behave, using tissue samples collected during routine care.
This study follows people who were treated for childhood cancer and compares them with similar adults who did not have that childhood cancer. It aims to learn about long-term health and especially walking or mobility issues over time, using check-ins that may include a mobility assessment.
Hear when a new All Malignancies trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.